RedHill Biopharma Ltd.
RDHL
$2.26
$0.199.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.27M | -19.22M | -30.17M | -27.87M | -- |
| Total Depreciation and Amortization | 619.00K | 721.00K | 823.00K | -58.29M | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.77M | 3.36M | 10.49M | 71.86M | -- |
| Change in Net Operating Assets | 2.05M | -1.66M | -5.37M | -17.43M | -- |
| Cash from Operations | -9.37M | -16.80M | -24.23M | -31.73M | -- |
| Capital Expenditure | -9.00K | -7.00K | -5.00K | -11.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 7.50K | 15.00K | 15.00K | -- |
| Cash from Investing | -9.00K | 500.00 | 10.00K | 3.50K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -636.00K | -818.00K | -1.00M | -1.09M | -- |
| Issuance of Common Stock | 8.26M | 12.69M | 17.13M | 12.99M | -- |
| Repurchase of Common Stock | -- | -- | -- | -1.61M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 790.00K | 4.60M | 8.40M | 10.28M | -- |
| Cash from Financing | 8.42M | 16.47M | 24.53M | 20.58M | -- |
| Foreign Exchange rate Adjustments | 9.00K | -8.00K | -25.00K | -4.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -952.00K | -335.50K | 281.00K | -11.15M | -- |